Spots Global Cancer Trial Database for Safety Evaluation Study for Patients With Polycythemia Vera
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety Evaluation Study for Patients With Polycythemia Vera
Official Title: Phase I, Open-Label, Multicentre, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of A Single Intravenous PPMX-T003 in Polycythemia Vera
Study ID: NCT05074550
Conditions
Interventions
Study Description
Brief Summary: This is PhaseI Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of PPMX-T003 in Polycythemia Vera
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kansai Medical University Hospital, Hirakata, Osaka, Japan
Shimane University Hospital, Izumo, Shimane, Japan
Osaka City University Hospital, Osaka, , Japan
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
